China Proposes Controls on Biotechnology Platform Transfers

Company MOFCOM and MOST (China Ministry of Commerce and Ministry of Science and Technology) Event Type Regulatory / Policy (Proposed Technology-Export Catalogue Amendment) Modality Cell and gene therapy platforms; small-nucleic-acid drug platforms; novel-target discovery technologies Asset Not applicable (platform-level policy) Target Not applicable Disease Area…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *